Here are three to note:
Parsippany-Troy Hills, N.J.-based Allergan elected Adriane Brown to its board of directors. Ms. Brown is the current president and COO of Bellevue, Wash.-based Intellectual Ventures.
Ahead of its stock offering, the FDA approved New York City-based Synergy Pharmaceuticals’ plecanatide. The drug treats chronic idiopathic constipation in adults.
After President Donald Trump demanded pharmaceutical companies offer cheaper drugs, Japan-based Takeda renewed its commitment to its single-digit annual increase pricing model. President Trump would like pharmaceutical companies to lower prices and produce more drugs in the United States.
Takeda’s Chief Executive Christophe Weber said in a results briefing that “Takeda has for many years been reasonable in its price increases in the United States and we are very committed to single-digit price increase [model].”
More articles on gastroenterology/endoscopy:
GI leader to know: Dr. Indira Reddy of Wake Endoscopy Center
Can pregnant women undergo endoscopy? 3 study insights
Chemotherapy overused for young, middle-aged adults with colon cancer, no improvement in survival rate: 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.